The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Desloratadine-Global Market Insights and Sales Trends 2024
Synopsis
Desloratadine is an antihistamine that is used to get relieve from allergic symptoms, such as sneezing, runny nose, and rashes due to chronic reactions.
The global Desloratadine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Desloratadine in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Desloratadine market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Desloratadine market, driven by demand from China, the second largest economy with some signs of stabilising, the Desloratadine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Desloratadine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Desloratadine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Desloratadine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Desloratadine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Desloratadine covered in this report include Merck, Mylan, Lupin Pharmaceuticals, Sun Pharmaceutical, Dr.Reddy's, Guagndong Jiuming, Hainan Poly Pharm and Chengdu Mingri, etc.
The global Desloratadine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Mylan
Lupin Pharmaceuticals
Sun Pharmaceutical
Dr.Reddy's
Guagndong Jiuming
Hainan Poly Pharm
Chengdu Mingri
Global Desloratadine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Desloratadine market, Segment by Type:
Tablets
Injection
Global Desloratadine market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Desloratadine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Desloratadine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Desloratadine is an antihistamine that is used to get relieve from allergic symptoms, such as sneezing, runny nose, and rashes due to chronic reactions.
The global Desloratadine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Desloratadine in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Desloratadine market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Desloratadine market, driven by demand from China, the second largest economy with some signs of stabilising, the Desloratadine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Desloratadine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Desloratadine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Desloratadine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Desloratadine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Desloratadine covered in this report include Merck, Mylan, Lupin Pharmaceuticals, Sun Pharmaceutical, Dr.Reddy's, Guagndong Jiuming, Hainan Poly Pharm and Chengdu Mingri, etc.
The global Desloratadine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Mylan
Lupin Pharmaceuticals
Sun Pharmaceutical
Dr.Reddy's
Guagndong Jiuming
Hainan Poly Pharm
Chengdu Mingri
Global Desloratadine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Desloratadine market, Segment by Type:
Tablets
Injection
Global Desloratadine market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Desloratadine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Desloratadine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Desloratadine Market Overview
1.1 Desloratadine Product Overview
1.2 Desloratadine Market Segment by Type
1.2.1 Tablets
1.2.2 Injection
1.3 Global Desloratadine Market Size by Type
1.3.1 Global Desloratadine Market Size Overview by Type (2018-2029)
1.3.2 Global Desloratadine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Desloratadine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Desloratadine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Desloratadine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Desloratadine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Desloratadine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Desloratadine Sales Breakdown by Type (2018-2023)
2 Global Desloratadine Market Competition by Company
2.1 Global Top Players by Desloratadine Sales (2018-2023)
2.2 Global Top Players by Desloratadine Revenue (2018-2023)
2.3 Global Top Players by Desloratadine Price (2018-2023)
2.4 Global Top Manufacturers Desloratadine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Desloratadine Market Competitive Situation and Trends
2.5.1 Desloratadine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Desloratadine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Desloratadine as of 2022)
2.7 Date of Key Manufacturers Enter into Desloratadine Market
2.8 Key Manufacturers Desloratadine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Desloratadine Status and Outlook by Region
3.1 Global Desloratadine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Desloratadine Historic Market Size by Region
3.2.1 Global Desloratadine Sales in Volume by Region (2018-2023)
3.2.2 Global Desloratadine Sales in Value by Region (2018-2023)
3.2.3 Global Desloratadine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Desloratadine Forecasted Market Size by Region
3.3.1 Global Desloratadine Sales in Volume by Region (2024-2029)
3.3.2 Global Desloratadine Sales in Value by Region (2024-2029)
3.3.3 Global Desloratadine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Desloratadine by Application
4.1 Desloratadine Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Desloratadine Market Size by Application
4.2.1 Global Desloratadine Market Size Overview by Application (2018-2029)
4.2.2 Global Desloratadine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Desloratadine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Desloratadine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Desloratadine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Desloratadine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Desloratadine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Desloratadine Sales Breakdown by Application (2018-2023)
5 North America Desloratadine by Country
5.1 North America Desloratadine Historic Market Size by Country
5.1.1 North America Desloratadine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Desloratadine Sales in Volume by Country (2018-2023)
5.1.3 North America Desloratadine Sales in Value by Country (2018-2023)
5.2 North America Desloratadine Forecasted Market Size by Country
5.2.1 North America Desloratadine Sales in Volume by Country (2024-2029)
5.2.2 North America Desloratadine Sales in Value by Country (2024-2029)
6 Europe Desloratadine by Country
6.1 Europe Desloratadine Historic Market Size by Country
6.1.1 Europe Desloratadine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Desloratadine Sales in Volume by Country (2018-2023)
6.1.3 Europe Desloratadine Sales in Value by Country (2018-2023)
6.2 Europe Desloratadine Forecasted Market Size by Country
6.2.1 Europe Desloratadine Sales in Volume by Country (2024-2029)
6.2.2 Europe Desloratadine Sales in Value by Country (2024-2029)
7 Asia-Pacific Desloratadine by Region
7.1 Asia-Pacific Desloratadine Historic Market Size by Region
7.1.1 Asia-Pacific Desloratadine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Desloratadine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Desloratadine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Desloratadine Forecasted Market Size by Region
7.2.1 Asia-Pacific Desloratadine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Desloratadine Sales in Value by Region (2024-2029)
8 Latin America Desloratadine by Country
8.1 Latin America Desloratadine Historic Market Size by Country
8.1.1 Latin America Desloratadine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Desloratadine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Desloratadine Sales in Value by Country (2018-2023)
8.2 Latin America Desloratadine Forecasted Market Size by Country
8.2.1 Latin America Desloratadine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Desloratadine Sales in Value by Country (2024-2029)
9 Middle East and Africa Desloratadine by Country
9.1 Middle East and Africa Desloratadine Historic Market Size by Country
9.1.1 Middle East and Africa Desloratadine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Desloratadine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Desloratadine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Desloratadine Forecasted Market Size by Country
9.2.1 Middle East and Africa Desloratadine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Desloratadine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Desloratadine Products Offered
10.1.5 Merck Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Desloratadine Products Offered
10.2.5 Mylan Recent Development
10.3 Lupin Pharmaceuticals
10.3.1 Lupin Pharmaceuticals Company Information
10.3.2 Lupin Pharmaceuticals Introduction and Business Overview
10.3.3 Lupin Pharmaceuticals Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lupin Pharmaceuticals Desloratadine Products Offered
10.3.5 Lupin Pharmaceuticals Recent Development
10.4 Sun Pharmaceutical
10.4.1 Sun Pharmaceutical Company Information
10.4.2 Sun Pharmaceutical Introduction and Business Overview
10.4.3 Sun Pharmaceutical Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sun Pharmaceutical Desloratadine Products Offered
10.4.5 Sun Pharmaceutical Recent Development
10.5 Dr.Reddy's
10.5.1 Dr.Reddy's Company Information
10.5.2 Dr.Reddy's Introduction and Business Overview
10.5.3 Dr.Reddy's Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Dr.Reddy's Desloratadine Products Offered
10.5.5 Dr.Reddy's Recent Development
10.6 Guagndong Jiuming
10.6.1 Guagndong Jiuming Company Information
10.6.2 Guagndong Jiuming Introduction and Business Overview
10.6.3 Guagndong Jiuming Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Guagndong Jiuming Desloratadine Products Offered
10.6.5 Guagndong Jiuming Recent Development
10.7 Hainan Poly Pharm
10.7.1 Hainan Poly Pharm Company Information
10.7.2 Hainan Poly Pharm Introduction and Business Overview
10.7.3 Hainan Poly Pharm Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hainan Poly Pharm Desloratadine Products Offered
10.7.5 Hainan Poly Pharm Recent Development
10.8 Chengdu Mingri
10.8.1 Chengdu Mingri Company Information
10.8.2 Chengdu Mingri Introduction and Business Overview
10.8.3 Chengdu Mingri Desloratadine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Chengdu Mingri Desloratadine Products Offered
10.8.5 Chengdu Mingri Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Desloratadine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Desloratadine Industrial Chain Analysis
11.4 Desloratadine Market Dynamics
11.4.1 Desloratadine Industry Trends
11.4.2 Desloratadine Market Drivers
11.4.3 Desloratadine Market Challenges
11.4.4 Desloratadine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Desloratadine Distributors
12.3 Desloratadine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
